In this study, we designed a peptide vaccine against angiotensin II (Ang II) by linking the Tfh epitope with angiotensin II (Tfh-AngII) and evaluated the efficiency of the Tfh-AngII vaccine in inducing Tfh cells and GC B cells and mitigating hypertension in a mouse model. The gene discussed is AGT; the disease is hypertensive disorder.